# FAST-01 (NCT04592887)

> Feasibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: symptomatic bone metastases

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT04592887
- Phase: NA
- Status: COMPLETED
- Sponsor: Varian, a Siemens Healthineers Company
- Conditions: Bone Metastasis
- Interventions: FLASH Radiotherapy
- Enrollment: 10
- Primary outcome: Workflow Feasibility
- Primary outcome: Workflow Feasibility
- Primary outcome: Assessment of Radiation-related Toxicities That Are Possibly, Probably, or Definitely Related to FLASH Radiotherapy.

## Indexed commentary on FAST-01 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 16 posts on X
- 1 YouTube video

## Order

Standard, $1,250 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=fast-01-nct04592887

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT04592887", "email": "<work email>"}; the inbox owner confirms by the emailed link.
